Biotech

All Articles

AstraZeneca spends CSPC $100M for preclinical cardiovascular disease drug

.AstraZeneca has settled CSPC Pharmaceutical Team $100 million for a preclinical cardiovascular dise...

Zephyrm finds Hong Kong IPO to money period 3 tissue therapy tests

.Zephyrm Bioscience is actually gusting toward the Hong Kong stock exchange, filing (PDF) for an IPO...

Frazier Life Sciences gets $630M for small, mid-cap biotechs

.Frazier Life Sciences has actually sourced an even more $630 million for its fund paid attention to...

GigaGen garners as much as $135M BARDA money to beat botulism

.Antibody connoisseur GigaGen, a subsidiary of Spanish biopharma Grifols, is ramping up its tech to ...

GPCR agency Septerna apply for IPO on toughness of preclinical records

.Septerna will discover exactly how a biotech without "any kind of meaningful scientific information...

Kurma closes to begin with $154M haul for biggest biotech fund as yet

.European VC company Kurma Partners has actually introduced its most current biotech fund, along wit...

Prothena markets one director while another leaves-- Chutes &amp Ladders

.Welcome to recently's Chutes &amp Ladders, our roundup of significant leadership hirings, firings a...

Editas cashes in on Tip Cas9 licensing civil liberties for $57M

.Versus the background of a Cas9 license struggle that refuses to die, Editas Medicine is actually m...

Ultragenyx tweaks genetics therapy dosing to dial up efficacy

.A minority of individuals taking Ultragenyx Pharmaceutical's Wilson disease gene treatment UX701 ha...

Biopharma discharge fee maintains in Q3: Tough Biotech analysis

.As summer heat counts on cool winds, wishes that this year would bring wide-spread business relief ...